StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research report issued on Tuesday. The firm set a “sell” rating on the stock.
Ampio Pharmaceuticals Price Performance
Shares of AMPE opened at $0.01 on Tuesday. Ampio Pharmaceuticals has a 52-week low of $0.00 and a 52-week high of $2.47. The stock has a fifty day simple moving average of $0.01 and a two-hundred day simple moving average of $0.01. The company has a market capitalization of $11,400.00, a PE ratio of 0.00 and a beta of 3.66.
Ampio Pharmaceuticals Company Profile
See Also
- Five stocks we like better than Ampio Pharmaceuticals
- Find and Profitably Trade Stocks at 52-Week Lows
- Merck: 4 No-Brainer Reasons to Buy This Dip
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- What Are the FAANG Stocks and Are They Good Investments?
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
